首页> 外文期刊>BMC Complementary and Alternative Medicine >Synergistic study of a Danshen (Salvia Miltiorrhizae Radix et Rhizoma) and Sanqi (Notoginseng Radix et Rhizoma) combination on cell survival in EA.hy926 cells
【24h】

Synergistic study of a Danshen (Salvia Miltiorrhizae Radix et Rhizoma) and Sanqi (Notoginseng Radix et Rhizoma) combination on cell survival in EA.hy926 cells

机译:丹参和三七组合对EA.hy926细胞存活的协同研究

获取原文
       

摘要

This study investigated the protective effects of the Danshen (DS) and Sanqi (SQ) herb pair on cell survival in the human cardiovascular endothelial (EA.hy926) cell line exposed to injury. Nine combination ratios of Danshen-Sanqi extracts (DS-SQ) were screened for their protective effects in the EA.hy926 cell line against two different cellular impairments induced by DL-homocysteine (Hcy) – adenosine (Ado) – tumour necrosis factors (TNF) and oxidative stress (H2O2), respectively. The type of interaction (synergistic, antagonistic, additive) between DS and SQ was analysed using a combination index (CI) model. The effects of key bioactive compounds from DS and SQ were tested using the same models. The compound from each herb that demonstrated the most potent activity in cell viability was combined to evaluate their synergistic/antagonistic interaction using CI. DS-SQ ratios of 6:4 (50–300?μg/mL) produced synergistic effects (CI??1) in restoring cell viability, reducing lactate dehydrogenase (LDH) leakage and caspase-3 expressions against Hcy-Ado-TNF. Additionally, DS-SQ 6:4 (50–150?μg/mL) was found to synergistically protect endothelial cells from impaired cellular injury induced by oxidative damage (H2O2) by restoring reduced cell viability and inhibiting excessive expression of reactive oxygen species (ROS). In particular, the combination of salvianolic acid A (SA) and ginsenoside Rb1 (Rb1) at 4:6 (1–150?μM) showed synergistic effects in preventing cytotoxic effects caused by Hcy-Ado-TNF (CI??1). This simplified combination also demonstrated synergistic effects on H2O2-induced oxidative damage on EA.hy926 cells. This study provides scientific evidence to support the traditional use of the DS-SQ combination on protecting endothelial cells through their synergistic interactions.
机译:这项研究调查了丹参(DS)和三七(SQ)草药对对暴露于损伤的人心血管内皮(EA.hy926)细胞系中细胞存活的保护作用。筛选了9种配比的丹参三七提取物(DS-SQ)在EA.hy926细胞系中对DL-高半胱氨酸(Hcy)–腺苷(Ado)–肿瘤坏死因子(TNF)诱导的两种不同细胞损伤的保护作用)和氧化应激(H2O2)。 DS和SQ之间的相互作用类型(协同,拮抗,加和)使用组合指数(CI)模型进行了分析。使用相同的模型测试了来自DS和SQ的关键生物活性化合物的效果。使用CI将每种草药中表现出最强活性的化合物混合在一起,以评估它们的协同/拮抗相互作用。 DS-SQ比为6:4(50-300?μg/ mL)在恢复细胞活力,减少乳酸脱氢酶(LDH)泄漏和针对Hcy-Ado-TNF的caspase-3表达方面产生了协同作用(CI?<?1) 。此外,发现DS-SQ 6:4(50–150?μg/ mL)通过恢复降低的细胞活力并抑制过度表达的活性氧(ROS),协同保护内皮细胞免受氧化损伤(H2O2)诱导的细胞损伤。 )。特别是,丹酚酸A(SA)和人参皂甙Rb1(Rb1)在4:6(1-150μM)的组合显示出协同作用,可预防Hcy-Ado-TNF(CI?<?1)引起的细胞毒性作用。 。这种简化的组合还显示出对H2O2诱导的EA.hy926细胞氧化损伤的协同作用。这项研究提供了科学证据,以支持传统的DS-SQ组合通过协同作用保护内皮细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号